Setting analytical performance specifications based on outcome studies – is it possible?
暂无分享,去创建一个
P. Bossuyt | S. Sandberg | S. Lord | A. Horvath | C. Cobbaert | A. John | P. Monaghan | W. Verhagen-Kamerbeek | C. Ebert | L. Lennartz | for the Test Evaluation Working Group of the Europ
[1] D. Fitzmaurice,et al. Self-monitoring and self-management of oral anticoagulation. , 2016, The Cochrane database of systematic reviews.
[2] T. Merlin. The use of the 'linked evidence approach' to guide policy on the reimbursement of personalized medicines. , 2014, Personalized medicine.
[3] W. Fraser,et al. Variability in parathyroid hormone assays confounds clinical practice in chronic kidney disease patients , 2014, Annals of clinical biochemistry.
[4] Sverre Sandberg,et al. From biomarkers to medical tests: the changing landscape of test evaluation. , 2014, Clinica chimica acta; international journal of clinical chemistry.
[5] Tony Badrick. Evidence-based laboratory medicine. , 2013, The Clinical biochemist. Reviews.
[6] A. Tislér,et al. Switching between parathormone (PTH) assays: the impact on the diagnosis of renal osteodystrophy , 2012, Clinical chemistry and laboratory medicine.
[7] Anne Eisinga,et al. A capture-recapture analysis demonstrated that randomized controlled trials evaluating the impact of diagnostic tests on patient outcomes are rare. , 2012, Journal of clinical epidemiology.
[8] P. Bossuyt,et al. Assessing the value of diagnostic tests: a framework for designing and evaluating trials , 2012, BMJ : British Medical Journal.
[9] T. Christensen. Self-management of oral anticoagulation therapy--methodological and clinical aspects. , 2011, Danish medical bulletin.
[10] G. Klee,et al. [Establishment of outcome-related analytic performance goals]. , 2011, Annales de biologie clinique.
[11] George G Klee,et al. Glucose meter performance criteria for tight glycemic control estimated by simulation modeling. , 2010, Clinical chemistry.
[12] S. Teutsch,et al. Outcomes of interest in evidence-based evaluations of genetic tests , 2010, Genetics in Medicine.
[13] D. Fitzmaurice,et al. Self-monitoring and self-management of oral anticoagulation. , 2010, The Cochrane database of systematic reviews.
[14] Joseph Lau,et al. Decision-Analytic Modeling to Evaluate Benefits and Harms of Medical Tests: Uses and Limitations , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.
[15] Patrick M M Bossuyt,et al. Using the Principles of Randomized Controlled Trial Design to Guide Test Evaluation , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.
[16] Kirsten McCaffery,et al. Additional Patient Outcomes and Pathways in Evaluations of Testing , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.
[17] J. Lijmer,et al. Various randomized designs can be used to evaluate medical tests. , 2009, Journal of clinical epidemiology.
[18] Sarah Lord,et al. When Is Measuring Sensitivity and Specificity Sufficient To Evaluate a Diagnostic Test, and When Do We Need Randomized Trials? , 2006, Annals of Internal Medicine.
[19] M. Bissell. Laboratory-Related Measures of Patient Outcomes: An Introduction , 2000 .
[20] C G Fraser,et al. Introduction: strategies to set global quality specifications in laboratory medicine. , 1999, Scandinavian journal of clinical and laboratory investigation.
[21] P. H. Petersen,et al. Analytical performance characteristics should be judged against objective quality specifications. , 1999, Clinical chemistry.
[22] M Werner,et al. Linking analytic performance goals to medical outcome. , 1997, Clinica chimica acta; international journal of clinical chemistry.
[23] W. Hamilton. Measures of Outcome , 1986 .